Search Results - "Stephen Kegg"

Refine Results
  1. 1
  2. 2

    Hepatitis B, hepatitis C and mortality among HIV-positive individuals by Thornton, Alicia C, Jose, Sophie, Bhagani, Sanjay, Chadwick, David, Dunn, David, Gilson, Richard, Main, Janice, Nelson, Mark, Rodger, Alison, Taylor, Chris, Youssef, Elaney, Leen, Clifford, Gompels, Mark, Kegg, Stephen, Schwenk, Achim, Sabin, Caroline

    Published in AIDS (London) (28-11-2017)
    “…OBJECTIVES:To compare rates of all-cause, liver-related and AIDS-related mortality among individuals who are HIV mono-infected with those co-infected with HIV…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Who gets single tablet regimens (STR), and why? by Tarrier, Laura, Kegg, Stephen

    Published in Journal of the International AIDS Society (01-11-2014)
    “…Introduction The BHIVA guidelines now feature three single tablet regimens (STRs) as recommended treatments for HIV‐positive people new to therapy [1]. They…”
    Get full text
    Journal Article
  5. 5

    HIV outcomes during the COVID‐19 pandemic in people of Black ethnicities living with HIV in England by Ottaway, Zoe, Campbell, Lucy, Fox, Julie, Burns, Fiona, Hamzah, Lisa, Kegg, Stephen, Rosenvinge, Melanie, Schoeman, Sarah, Price, David, Jones, Rachael, Miller, Robert F., Tariq, Shema, Post, Frank A.

    Published in HIV medicine (01-07-2024)
    “…Objectives To describe HIV care outcomes in people of Black ethnicities living in England during the severe acute respiratory syndrome coronavirus 2…”
    Get full text
    Journal Article
  6. 6

    Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom by Ko, Stephanie, Dominguez-Dominguez, Lourdes, Ottaway, Zoe, Campbell, Lucy, Fox, Julie, Burns, Fiona, Hamzah, Lisa, Ustianowski, Andrew, Clarke, Amanda, Kegg, Stephen, Schoeman, Sarah, Jones, Rachael, Pett, Sarah L, Hudson, Jonathan, Post, Frank A

    Published in HIV medicine (29-08-2024)
    “…Our objective was to describe the prevalence of cardiovascular disease (CVD) risk factors in people of African ancestry with HIV in the UK. We conducted a…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial by Squires, Kathleen, Cahn, Pedro, Lombaard, Johan, DeJesus, Edwin, Lai, Ming-Tain, Rodgers, Anthony, Kumar, Sushma, Sklar, Peter, Nguyen, Bach-Yen, Hanna, George J, Hwang, Carey, Martins, Marcelo, Bloch, Mark Theo, Baker, David Alfred, Roth, Norman, Moore, Richard James, McMahon, James, Rieger, Armin, Zoufaly, Alexander, Zangerle, Robert, Smaill, Fiona, Rachlis, Anita, Perez, Carlos, Campos Barker, Maria Isabel E., Wolff Reyes, Marcelo, Laursen, Alex Lund, Molina, Jean-Michel, Yazdanpanah, Yazdan, Cotte, Laurent, Raffi, Francois, Morlat, Philippe, Girard, Pierre-Marie, Katlama, Christine, Rockstroh, Juergen K., Arasteh, Keikawus, Stoehr, Albrecht, Stellbrink, Hans-Juergen, Stoll, Matthias, Schuermann, Dirk, Faetkenheuer, Gerd, Bogner, Johannes, Gori, Andrea, Coltan, Gabriel, Constandis, Felicia, Erscoiu, Simona Manuela, Pokrovsky, Vadim Valentinovich, Shuldyakov, Andrey Anatolyevich, Ryamova, Elena Pavlovna, Kulagin, Valeriy Viktorovich, Tsybakova, Olga Aleksandrovna, Orlova-Morozova, Elena, Shimonova, Tatyana Evgenyevna, Kozyrev, Oleg Anatolyevich, Orrell, Catherine, Lombaard, Johannes Jurgens, Botes, Margaretha Elizabeth, Portilla, Joaquin, Gatell, Josep Maria, Perez, Maria Jesus, Arribas, Jose Ramon, Negredo, Eugenia, Podzamczer, Daniel, Troya, Jesus, De los Santos, Ignacio, Berenguer, Juan, Williams, Ian G., Johnson, Margaret A., Schembri, Gabriel, Gompels, Mark, Fox, Julie Meriel, Taylor, Steven John, Kegg, Stephen, Hagins, Debbie P., Osiyemi, Olayemi O., Prelutsky, David James, Ramgopal, Moti N., Dretler, Robin, DeJesus, Edwin, Sloan, Louis, Lewis, Stanley T., Clay, Patrick G., Bellos, Nicholaos C., Montero, Jose, Creticos, Catherine, Shamblaw, David, Valdes, Martin, Felizarta, Franco Antonio, Slim, Jihad, Lalezari, Jacob Paul, Ruane, Peter Jerome, Cade, Jerry L., Campo, Rafael E., Blick, Gary, Mayer, Cynthia, Daar, Eric, Kumar, Princy N., Swindells, Susan, Castro, Jose Guillermo, Santiago, Lizette, Santana-Bagur, Jorge L.

    Published in The lancet HIV (01-05-2018)
    “…Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro…”
    Get full text
    Journal Article
  9. 9

    Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial by Ogbuagu, Onyema, Ruane, Peter J, Podzamczer, Daniel, Salazar, Laura C, Asmuth, David M, Wohl, David, Gilson, Richard, Shao, Yongwu, Cox, Stephanie, Kintu, Alexander, Carter, Christoph, Baeten, Jared M, Brainard, Diana M, Whitlock, Gary, Brunetta, Jason M, Spinner, Christoph D, Antinori, Andrea, Apea, Vanessa, Avery, Ann, Benson, Paul, Bergin, Colm, Berhe, Mezgebe, Brar, Indira, Brinson, Cynthia, Brunetta, Jason, Burack, Jeffrey, Campbell, Thomas, Cespedes, Michelle, Clarke, Amanda, Coleman, Megan, Coll, Josep, Crespo Casal, Manuel, Creticos, Catherine, Crofoot, Gordon, Cruickshank, Frederick, Cua, Eric, Daar, Eric, de Wet, Joseph, DeJesus, Edwin, Del Romero Guerrero, Jorge, Dinges, William, Donovan, Taylor, Flamm, Jason, Gallant, Joel, Gerstoft, Jan, Gilson, Richard, Gladstein, Jay, Grant, Robert, Halperin, Jason, Hardy, W. David, Hare, Charles, Hassler, Shawn, Hengel, Richard, Henry, William, Hodge, Theo, Iandiorio, Michelle, Jessen, Heiko, Kegg, Stephen, Knecht, Gabriele, Krznaric, Ivanka, Larsen, Olav Ditlevsen, Lazzarin, Adriano, Leen, Clifford, Lucasti, Christopher, Mallon, Patrick, Mannheimer, Sharon, Markowitz, Martin, Martorell, Claudia, Mayer, Kenneth, Mills, Anthony, Molina, Jean-Michel, Morris, Sheldon, Mounzer, Karam, Nwokolo, Nneka, Osiyemi, Olayemi, Petroll, Andrew, Philibert, Patrick, Phoenix, John, Pialoux, Gilles, Podzamczer, Daniel, Post, Frank, Rashbaum, Bruce, Reeves, Iain, Richmond, Gary, Salazar, Laura, Scarsella, Anthony, Schembri, Gabriel, Scott, Mia, Sinclair, Gary, Sobieszczyk, Magdalena, Spinner, Christoph, Stephens, Jeffrey, Szabo, Jason, Tremblay, Cecile, Trottier, Benoit, Voskuhl, Gene, Wohl, David, Workowski, Kimberly, Yawetz, Sigal, Young, Benjamin

    Published in The lancet HIV (01-07-2021)
    “…In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Clinical epidemiology of COVID‐19 in people of black ethnicity living with HIV in the UK by Ottaway, Zoe, Campbell, Lucy, Cechin, Laura R., Patel, Nisha, Fox, Julie, Rosenvinge, Melanie, Schoeman, Sarah, Price, David, Jones, Rachael, Clarke, Amanda, Maan, Irfaan, Ustianowski, Andrew, Onyango, Denis, Tariq, Shema, Miller, Robert F., Post, Frank A., Clarke, Amanda, Knott, Alyson, Trevitt, Vittorio, Schoolmeesters, Alex, Ghazali, Shoreh, Fox, Julie, Waters, Anele, Racz, Mariusz, Arbis, Kathy, Post, Frank, Ottaway, Zoe, Santana‐Suarez, Beatriz, McQueen, Leigh, Campbell, Lucy, Barbini, Bee, Wandolo, Emily, Hung, Rachel, Hanbury, Luella, Barber, Sarah, Taylor, Chris, Poulton, Mary, Middleditch, Holly, McDonald, Candice, Kolodin, Vladimir, Cechin, Laura, Mulka, Larissa, John, Amy, Hawkins, Sally, Bainbridge, Katherine, Barker, Julie, Childs, Kate, Shorrock, Lisa, El Bouzidi, Kate, Oliveira, Amelia, Ratnappuli, Ayoma, Flanagan, Kate, Mody, Nisha, Brady, Michael, Quinn, Killian, Hamlyn, Elizabeth, Sandhu, Gurjinder, Sullivan, Verity, Fitzgerald, Naomi, Schoeman, Sarah, Lamont, Gary, Calder‐Smith, Natasha, Mazeika, Tadas, Chana, Kiran, Ustianowski, Andrew, Lindergard, Gabriella, Flaherty, Jan, George, Valerie, Kadiu, Denise, Hendy, Alice, Kuriakose, Kevin, Pett, Sarah, Qamar, Mah Jabeen, Sosa, Jose Paredes, Tetorou, Konstantina, Beynon, Michelle, Yinka‐Ogunleye, Adesola, Gopalakrishnan, Gosala, Maan, Irfaan, Mullender, Claire, Price, David Ashley, Patel, Bijal, McVittie, Ian, Kegg, Stephen, Harrington, Rosa, Cunningham, Kirsty, Lewis, Mandy, Edwards, Jonathan, Fernandez, Tom, Egeh, Qayo, Spears, Katie, Hamzah, Lisa, Cosgrove, Catherine, Laurence, Hannah, Rahman, Ameen, Toler, Katie, Rosenvinge, Melanie, Adade, Claudia, Campbell, Shelley, Onyango, Denis

    Published in HIV medicine (01-05-2024)
    “…Objectives To describe the clinical epidemiology of COVID‐19 in people of black ethnicity living with HIV in the UK. Methods We investigated the incidence and…”
    Get full text
    Journal Article
  12. 12

    Chronic Kidney Disease Risk in African and Caribbean Populations With HIV by Jose, Sophie, Hamzah, Lisa, Jones, Rachael, Williams, Debbie, Winston, Alan, Burns, Fiona, Phillips, Andrew N, Sabin, Caroline A, Post, Frank A

    Published in The Journal of infectious diseases (20-10-2018)
    “…We conducted an observational cohort study of end-stage kidney disease (ESKD) in >7000 African and Caribbean people with HIV in the UK. Using Poisson…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK by El Bouzidi, Kate, White, Ellen, Mbisa, Jean L, Sabin, Caroline A, Phillips, Andrew N, Mackie, Nicola, Pozniak, Anton L, Tostevin, Anna, Pillay, Deenan, Dunn, David T

    Published in Journal of antimicrobial chemotherapy (01-12-2016)
    “…Darunavir is considered to have a high genetic barrier to resistance. Most darunavir-associated drug resistance mutations (DRMs) have been identified through…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The contribution of viral genotype to plasma viral set-point in HIV infection by Hodcroft, Emma, Hadfield, Jarrod D, Fearnhill, Esther, Phillips, Andrew, Dunn, David, O'Shea, Siobhan, Pillay, Deenan, Leigh Brown, Andrew J

    Published in PLoS pathogens (01-05-2014)
    “…Disease progression in HIV-infected individuals varies greatly, and while the environmental and host factors influencing this variation have been widely…”
    Get full text
    Journal Article
  19. 19

    An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs by Smit, Erasmus, White, Ellen, Clark, Duncan, Churchill, Duncan, Zhang, Hongyi, Collins, Simon, Pillay, Deenan, Sabin, Caroline, Nelson, Mark, Winston, Alan, Jose, Sophie, Tostevin, Anna, Dunn, David T

    Published in Journal of antimicrobial chemotherapy (01-07-2017)
    “…HIV-1 subtype C might have a greater propensity to develop K65R mutations in patients with virological failure compared with other subtypes. However, the…”
    Get full text
    Journal Article
  20. 20

    Predicting virological decay in patients starting combination antiretroviral therapy by Hughes, Rachael

    Published in AIDS (London) (17-07-2016)
    “…OBJECTIVE:Model trajectories of viral load measurements from time of starting combination antiretroviral therapy (cART), and use the model to predict whether…”
    Get full text
    Journal Article